CDH1 and non-small cell lung carcinoma: First, we examined TGFβ responsiveness in three non-small-cell lung carcinoma (NSCLC) cell lines (HCC827, A549, H3255) towards bulk expression of widely accepted EMT markers (E-Cadherin, Vimentin, CD442,4,17) (Fig. 1a).